Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,145.50    -4.50 (-0.39%)
Bid:
1,142.00
Ask:
1,143.00
Spread: 1.00 (0.088%)
Market Cap: £5.83b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

30 Dec 2016 10:09

St. James’s Place plc (“SJP”)

SJP was notified on 30 December 2016 of the following changes in SJP shares held by the Executive Director named below.

SJP Performance Share Plan 2005 (“PSP”) and linked Company Share Option Plan 2010 (“CSOP”)

On 21 March 2013, Mr David Bellamy, Executive Director, was awarded a CSOP-linked award, whereby he was granted a nil-cost unapproved option pursuant to the PSP and a linked HMRC approved CSOP option. Mr Bellamy exercised the linked CSOP award on 29 December 2016 with an exercise price of £5.155 per share and, as a result, his linked PSP award automatically lapsed in respect of the number of shares equal in value to the gain realised upon exercise of the linked CSOP award.

Column 1 sets out the number of SJP shares acquired as a result of the exercise of the linked CSOP award on 29 December 2016, and column 2 sets out the number of SJP shares sold on 29 December 2016 at £9.89 per share by Mr Bellamy. Column 3 sets out the number of shares that have lapsed under the linked PSP award as a result of this exercise, and Column 4 sets out the number of PSP award shares retained under the linked PSP award.

1 2 3 4
Name of Director Number of SJP shares acquired on exercise of CSOP option Number of SJP shares sold Number of SJP shares that have lapsed under the linked PSP award Number of SP shares retained under the linked PSP award
David Bellamy 774 407 371 175,807

SJP Performance Share Plan 2005 (“PSP”)

On 21 March 2013 Mr Bellamy was awarded nil cost unapproved PSP awards. On 29 December 2016, Mr Bellamy exercised those awards, as set out in the table below.

Column 1 sets out the number of SJP shares exercised, column 2 sets out the number of SJP shares sold on 29 December 2016 at a price of £9.963 per share by Mr Bellamy in order to settle income tax and National Insurance liabilities. Column 3 sets out the number of SJP shares retained.

1 2 3
Name of Director Number of SJP shares exercised Number of SJP shares sold to meet tax liability Number of SJP shares retained
David Bellamy 175,807 82,837 92,970

Following the above, Mr Bellamy, on 30 December 2016 transferred 80,000 SJP shares by way of gift to members of his family. Mr Bellamy further transferred 13,337 SJP shares by way of gift to the Bellamy Family Trust (“the Trust”) held with the Charities Aid Foundation. Neither Mr Bellamy or a Person Closely Associated with him are Trustees of the Trust and none of the shares held in the Trust are held on his behalf on either a beneficial or non-beneficial basis.

Current Holdings

The table below sets out the current holdings of Mr Bellamy and his Closely Associated Persons* in SJP ordinary shares after the above transactions:

Name of Director Number of SJP shares held
David Bellamy 1,263,080

(i) \* The interests of the Director include those of his Closely Associated Person as defined in Regulation (EU) No 596/2014 (Market Abuse Regulation). The Closely Associated Person of Mr Bellamy is Janette Bellamy.

(ii) The interests of the Director include deferred bonus scheme awards held in trust for the Director which have not yet vested and are subject to forfeiture.

This notification is made in accordance with Article 19(3) of Regulation (EU) No 596/2014 (Market Abuse Regulation).

With the exception of the changes notified in this announcement, the Executive Directors’ shareholdings in SJP are unchanged.

Ann McGookin

Tel: +44 (0)1285 717318

View source version on businesswire.com: http://www.businesswire.com/news/home/20161230005114/en/

Copyright Business Wire 2016

Date   Source Headline
1st Jul 20212:54 pmRNSTotal Voting Rights
24th Jun 202110:41 amRNSHolding(s) in Company
1st Jun 202111:44 amRNSTotal Voting Rights
26th May 20217:00 amRNSCapital Markets Day and New Business Update
20th May 20214:48 pmRNSHolding(s) in Company
18th May 20213:09 pmRNSAdditional Listing
14th May 20211:18 pmRNSResult of AGM
7th May 20214:49 pmRNSDirector/PDMR Shareholding
4th May 20213:15 pmRNSDirector/PDMR Shareholding
4th May 202112:05 pmRNSHolding(s) in Company
4th May 202111:08 amRNSTotal Voting Rights
29th Apr 20217:00 amRNSQ1 New Business Inflows and Funds under Management
27th Apr 20214:35 pmRNSHolding(s) in Company
8th Apr 20214:32 pmRNSAnnual Report & Notice of AGM
1st Apr 20213:07 pmRNSTotal Voting Rights
31st Mar 20215:03 pmRNSCorrection: Director/PDMR Shareholding
29th Mar 20215:10 pmRNSDirector/PDMR Shareholding
17th Mar 20219:14 amRNSAdditional Listing
16th Mar 20219:50 amRNSDirector/PDMR Shareholding
16th Mar 20217:09 amRNSDirectorate Change
5th Mar 202112:53 pmRNSDirector/PDMR Shareholding
2nd Mar 20212:57 pmRNSDirector/PDMR Shareholding
1st Mar 20214:52 pmRNSTotal Voting Rights
25th Feb 20217:00 amRNSFinal Results
1st Feb 20215:02 pmRNSBlock listing Interim Review
1st Feb 20213:52 pmRNSTotal Voting Rights
1st Feb 20213:48 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSQ4 New Business Inflows and Funds Under Management
8th Jan 20212:44 pmRNSTotal Voting Rights - Replacement
8th Jan 202110:21 amRNSAdditional Listing
4th Jan 202112:01 pmRNSTotal Voting Rights
17th Dec 20209:20 amRNSDirectorate Change
1st Dec 202010:05 amRNSTotal Voting Rights
6th Nov 20209:41 amRNSDirector Declaration
2nd Nov 202011:07 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSQ3 New Business Inflows and Funds under Management
26th Oct 20209:39 amRNSStatement re Letter from Primestone LLP
23rd Oct 20207:22 amRNSHolding(s) in Company
21st Oct 20201:51 pmRNSDirector Declaration
7th Oct 20201:36 pmRNSDirector/PDMR Shareholding
1st Oct 20201:28 pmRNSTotal Voting Rights
18th Sep 202011:03 amRNSHolding(s) in Company
1st Sep 202011:00 amRNSTotal Voting Rights
19th Aug 20203:57 pmRNSHolding(s) in Company
7th Aug 20204:42 pmRNSHolding(s) in Company
5th Aug 202011:20 amRNSHolding(s) in Company
3rd Aug 20205:07 pmRNSBlock listing Interim Review - Amendment
3rd Aug 20204:57 pmRNSBlock listing Interim Review
3rd Aug 202010:19 amRNSTotal Voting Rights
28th Jul 20205:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.